Fighting viruses is as easy as breathing
The Pharma Data
APRIL 8, 2022
They also identified several drugs that reduced the production of inflammatory cytokines in infected Alveolus Chips, which could be useful in treating excessive inflammation in the lung. Based on these studies, one of those drugs was licensed to Cantex Pharmaceuticals for the treatment of COVID-19 and other inflammatory lung diseases.
52 
Let's personalize your content